Monday, October 2, 2017

Imprimis Secures First Key Composition Patent for Dropless Therapy ...

www.biospace.com/news_story.aspx?StoryID=471171&full=1
36 mins ago - Imprimis' Dropless Therapy® compounded antibiotic and steroid formulations ... Other than drugs compounded at a registered outsourcing facility, all Imprimis ...

FDA Unveils Ramped-up Regulatory Initiatives for Drug Compounders

FDA Unveils Ramped-up Regulatory Initiatives for Drug Compounders ...

www.jdsupra.com/legalnews/fda-unveils-ramped-up-regulatory-28010/
3 hours ago - These efforts demonstrate that FDA is continuing to actively oversee the regulation of
IA-66-40
Detention Without Physical Examination of Drugs From Firms Which Have Not Met Drug GMPs